Cardiac context
Plain-language framing for rhythm-related concerns and why screening may focus on them.
Information services / eligibility context
Services
Qadence organizes practical, evidence-aware information about ibogaine exclusion criteria: who may be screened out, deferred, or require a more careful discussion of risk.
These resources support clearer questions and safer context. They do not determine eligibility or replace clinical assessment.
Resource library
Information tools for a high-stakes topic
Qadence is an independent resource on ibogaine screening risks and eligibility. Its approach and limits are described in our mission and sourcing principles, while the broader ibogaine exclusion overview keeps the central safety questions in one place.
- Guides
- Screening
In-depth exclusion guides
Structured guides explain why particular histories, findings, or circumstances may lead to additional review, deferral, or exclusion. They distinguish a risk factor from a universal rule wherever the available evidence does not support certainty.
For a broader public-facing introduction, the ibogaine documentary resource offers another route into the subject.
- Frameworks
- Cardiac
Decision frameworks and cardiac context
Our framework separates questions that need a clinician from questions that can be understood ahead of time. It emphasizes that ibogaine has been associated with potentially serious cardiac rhythm concerns, including QT-related issues; the FDA’s drug development process also illustrates why investigational status and safety evaluation matter.
Readers seeking a focused discussion can compare concepts with the brain and aging perspective on ibogaine.
- Comparisons
- Settings
Comparison notes on settings and claims
Comparison notes help people recognize the difference between marketing language, a screening process, and a medical determination. They are designed for families and individuals trying to assess what questions a setting can realistically answer.
Examples of how facilities describe themselves can be reviewed through Mexico ibogaine center comparisons, without treating directory content as a safety endorsement.
- Research
- Glossary
Research summaries, glossary, and FAQs
Short summaries define terms that recur in screening discussions, including QT interval, contraindication, deferral, and monitoring. Long QT syndrome is one established example of a condition associated with an elevated arrhythmia concern, which is why terminology should be interpreted cautiously and in context.
For additional market and treatment-setting context, see the ibogaine industry reference and European treatment center overview.
How to use the material
A calmer path through complicated questions
Use these resources to prepare, not to self-clear. A decision about ibogaine can depend on details that only a qualified clinician and an appropriate care setting can evaluate.
- 01Identify the topic: cardiac history, medication exposure, psychiatric history, or setting limitations.
- 02Use the guide to clarify terms and write down specific questions without assuming an answer.
- 03Compare claims with the actual monitoring and referral limits described by a prospective setting.
- 04Bring relevant history to an appropriately qualified medical professional for individual guidance.
Reading the signal
What an information resource can—and cannot—do
Clear boundaries are part of useful safety communication, especially when the stakes of being wrong are high.
Useful for
Preparing questions
- Understanding terms used in screening conversations
- Recognizing possible reasons for a deferral
- Comparing stated monitoring and support claims
Core boundary
Not an eligibility decision
- No online guide can verify personal risk
- Medication and medical histories require individual review
- Investigational status does not equal established safety
Useful context
Evidence awareness
- Research summaries should be read with their limits
- Marketing language is not clinical evidence
- Risk may be shaped by multiple factors together
Frequently asked questions
Useful context without false certainty
“A screening exclusion is not a verdict on a person. It is a signal that risk, evidence, or the available setting deserves more careful consideration.”
Does a guide tell me whether I am eligible?
No. Guides can help identify questions and explain why a factor may matter, but they cannot make a medical determination. Qadence does not provide medical clearance, treatment, or clinical advice.
Why do medication questions appear so often?
Medication-related risk can depend on the specific medicine, dose, timing, other substances, and individual history. That is why practical resources should direct readers toward careful review rather than simple stop-or-go conclusions.
Where can I find a broader account of potential benefits?
The ibogaine benefits discussion may help frame commonly cited claims, but possible benefits do not remove the need to understand exclusions, uncertainty, and screening limits.
What should families look for in a resource?
Look for clear disclosure, uncertainty where it exists, and a distinction between explanation and advice. Our contact route for resource feedback is available for non-clinical questions about the site, not personal medical assessment.